Revvity Net Income 2010-2024 | RVTY

Revvity annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Revvity net income for the quarter ending September 30, 2024 was $0.094B, a 893.65% increase year-over-year.
  • Revvity net income for the twelve months ending September 30, 2024 was $0.254B, a 65.74% decline year-over-year.
  • Revvity annual net income for 2023 was $0.693B, a 21.77% increase from 2022.
  • Revvity annual net income for 2022 was $0.569B, a 39.65% decline from 2021.
  • Revvity annual net income for 2021 was $0.943B, a 29.57% increase from 2020.
Revvity Annual Net Income
(Millions of US $)
2023 $693
2022 $569
2021 $943
2020 $728
2019 $228
2018 $238
2017 $293
2016 $234
2015 $212
2014 $158
2013 $167
2012 $70
2011 $8
2010 $391
2009 $82
Revvity Quarterly Net Income
(Millions of US $)
2024-09-30 $94
2024-06-30 $55
2024-03-31 $26
2023-12-31 $79
2023-09-30 $9
2023-06-30 $36
2023-03-31 $569
2022-12-31 $128
2022-09-30 $85
2022-06-30 $179
2022-03-31 $177
2021-12-31 $190
2021-09-30 $128
2021-06-30 $246
2021-03-31 $379
2020-12-31 $380
2020-09-30 $177
2020-06-30 $137
2020-03-31 $34
2019-12-31 $65
2019-09-30 $59
2019-06-30 $69
2019-03-31 $35
2018-12-31 $71
2018-09-30 $77
2018-06-30 $64
2018-03-31 $26
2017-12-31 $-41
2017-09-30 $91
2017-06-30 $204
2017-03-31 $39
2016-12-31 $65
2016-09-30 $58
2016-06-30 $64
2016-03-31 $47
2015-12-31 $68
2015-09-30 $55
2015-06-30 $49
2015-03-31 $40
2014-12-31 $31
2014-09-30 $42
2014-06-30 $50
2014-03-31 $34
2013-12-31 $67
2013-09-30 $40
2013-06-30 $28
2013-03-31 $32
2012-12-31 $-16
2012-09-30 $30
2012-06-30 $34
2012-03-31 $23
2011-12-31 $-84
2011-09-30 $37
2011-06-30 $30
2011-03-31 $25
2010-12-31 $296
2010-09-30 $13
2010-06-30 $58
2010-03-31 $24
2009-12-31 $36
2009-09-30 $14
2009-06-30 $22
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical Services $15.535B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00